Skip to main navigation
Neurogene Inc.
Toggle Menu
  • Home
  • About Us
    • Our Leadership
    • A Message from Our Founder
  • Our Technology
    • Gene Therapy Platform
    • Manufacturing
    • Partnerships
  • Our Pipeline
    • About Rett Syndrome
    • About NGN-401
    • Rett Syndrome Clinical Program
    • Other Programs
    • Expanded Access Policy
    • Publications
  • Patients & Families
    • Our Approach
    • What is Rett Syndrome?
    • Rett Syndrome Resources
    • Rett Syndrome Clinical Program
    • Patient Advocacy & Engagement at Neurogene
    • Communication Corner
    • Rare Disease Community Resources
  • Investors
  • Careers
    • Life at Neurogene
    • Open Positions
    • Benefits

SEC Filing Details

decorative diamond pattern
  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Corporate Governance
    • Governance Overview
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • RSS Feeds
    • Investor Contacts

Document Details

Form
8-K
Filing Date
Jan 5, 2024
Document Date
Jan 5, 2024
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Neurogene Inc.
Issuer
NEUROGENE INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
Neurogene Inc.
  • About Us
  • Our Technology
  • Our Pipeline
  • Patients & Families
  • Investors
  • Careers
© 2026 Neurogene Inc. All Rights Reserved. Theme by SiteOrigin
Privacy  |  Terms of Use  |  Contact Us
Facebook   Linkedin   X
Scroll to top